Medtronic (XTER:2M6) EPS (Basic): €3.20 (TTM As of Apr. 2026)


XTER:2M6 Medtronic PLC XTER:2M6
75 GF Score
Price €70.50
GF Value €86.89
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic EPS (Basic)?

Medtronic XTER:2M6 +1.97% 75 EPS (Basic) is €3.20 as of Apr. 2026. GuruFocus rates XTER:2M6 with a GF Score™ of 75/100 and a GF Value™ of €86.89 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Medtronic's basic earnings per share (Basic EPS) for the three months ended in Apr. 2026 was €0.83. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Apr. 2026 was €3.20.

Medtronic's EPS (Diluted) for the three months ended in Apr. 2026 was €0.82. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was €3.19.

Medtronic's EPS without NRI for the three months ended in Apr. 2026 was €1.33. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2026 was 4.73.

During the past 12 months, Medtronic's average EPS without NRIGrowth Rate was 0.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 1.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 3.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Medtronic's highest 3-Year average EPS without NRI Growth Rate was 28.90% per year. The lowest was -2.40% per year. And the median was 11.40% per year.

Medtronic  (XTER:2M6) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medtronic EPS (Basic) Related Terms

Medtronic EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Medtronic's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic EPS (Basic) Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.47 2.58 2.58 3.23 3.21

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.69 0.92 0.76 0.83
XTER:2M6
75GF Score
Medtronic PLC XTER:2M6
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medtronic's Basic EPS for the fiscal year that ended in Apr. 2026 is calculated as

Basic EPS (A: Apr. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(4104.855-0)/1281.800
=3.20

Medtronic's Basic EPS for the quarter that ended in Apr. 2026 is calculated as

Basic EPS (Q: Apr. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1063.62-0)/1280.900
=0.83

EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €3.20 mean?
Medtronic (XTER:2M6) has a EPS (Basic) of €3.20 as of Apr. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medtronic and its competitors.
Is Medtronic's EPS (Basic) too high?
Medtronic's current EPS (Basic) is €3.20. Overall, Medtronic has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's EPS (Basic) compare to SYK and BSX?
Medtronic's EPS (Basic) of €3.20 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Medtronic and its competitors. Medtronic's current EPS (Basic) is €3.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XTER:2M6) is currently considered Modestly Undervalued. The stock's GF Value™ is €86.89, compared to a current price of €70.50 — trading 18.9% below its estimated fair value. The current EPS (Basic) is €3.20. Medtronic's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Medtronic (XTER:2M6), the current EPS (Basic) is €3.20 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (XTER:2M6) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of €70.50 is trading 18.9% below its estimated GF Value™ of €86.89. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for XTER:2M6:

  • EPS (Basic): €3.20
  • GF Value™: €86.89 vs. price of €70.50 (18.9% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the XTER:2M6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
75GF Score

Get the complete analysis for XTER:2M6

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.50
Price
€86.89
GF Value